Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order
AffiliationUniv Arizona, Coll Med, Coll Social & Behav Sci Family & Community Med, Southwest Inst Res Women
MetadataShow full item record
CitationEldridge, L. A., Agley, J., & Meyerson, B. E. (2020). Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order. Journal of the American Pharmacists Association.
RightsCopyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
AbstractObjectives: This study examined changes in rates of pharmacy naloxone stocking and dispensing in Indiana between 2016 and 2018 and explored supplemental variables and factors that may have affected observed differences. Methods: Researchers used data from 2 existing datasets that were collected from managing pharmacists who responded to statewide pharmacy censuses in 2016 and 2018. After identifying all cases in which a pharmacy's managing pharmacist responded in both 2016 and 2018 censuses, researchers conducted a nonparametric statistical comparison of naloxone stocking and dispensing rates in 107 Indiana pharmacies. Additional descriptive data regarding naloxone-related pharmacy policies and educational programs during those years were collected in 2019 from pharmacy corporations operating food stores or chain pharmacies in Indiana and from the Indiana Pharmacists Association. Results: Pharmacy stocking and dispensing in Indiana increased from 2016 to 2018. In 2016, 57% of pharmacies reported stocking naloxone compared with 92.5% in 2018 (P < 0.001). Similarly, 23.4% of pharmacies reported dispensing naloxone in 2016 compared with 76.6% of pharmacies in 2018 (P < 0.001). All responding pharmacy corporations and the state pharmacy association reported offering self-directed volunteer-training programs regarding naloxone since 2016. In addition, they reported that company policy and procedures regarding naloxone were put into place in response to the 2016 statewide standing order. Conclusion: Pharmacy naloxone stocking and dispensing increased in the 2 years after the statewide standing order was issued. The effect of the order itself was likely moderated or mediated by corporate responses to the law. Research examining the impact of naloxone-availability policies on pharmacy practice and patient incomes should longitudinally examine data after policy implementation and with covariates that include type of pharmacy (e.g., chain or independent), location, and opioid overdose-associated mortality rates. (C) 2020 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
Note12 month embargo; available online 06 January 2020
VersionFinal accepted manuscript
- Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016.
- Authors: Meyerson BE, Agley JD, Davis A, Jayawardene W, Hoss A, Shannon DJ, Ryder PT, Ritchie K, Gassman R
- Issue date: 2018 Jul 1
- Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.
- Authors: Sisson ML, McMahan KB, Chichester KR, Galbraith JW, Cropsey KL
- Issue date: 2019 Dec
- Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.
- Authors: Santa HM, Amirova SG, Ventricelli DJ, Downs GE, Nowalk AA, Pringle JL, Aruru M
- Issue date: 2021 Feb 8
- Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.
- Authors: Rudolph SE, Branham AR, Rhodes LA, Hayes HH Jr, Moose JS, Marciniak MW
- Issue date: 2018 Jul - Aug
- Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.
- Authors: Melaragni F, Levy C, Pedrazzi J, Andersen M
- Issue date: 2019 Jul - Aug